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Objectives: The host DNA sensor proteins TLR9, STING, IFI16 are central signaling
molecules that control the innate immune response to cytosolic nucleic acids. Here
we propose to investigate how Natural killer (NK) cell infection by human herpesvirus
(HHV)-6A, HHV-6B or HHV-7 is able to modify DNA sensor signaling in NK cells.
Methods: We infected the NK92 cell line and primary NK cells with cell-free inocula of
HHV-6A, HHV-6B or HHV-7 and evaluated TLR9, STING, and IFI16 pathway expression
by Real-Time PCR, Western Blot, immunofluorescence and flow cytometry for 1, 2, 3,
and 6 days post-infection. We evaluated NK cell cytokine-producing by Real-Time PCR
and enzyme immunosorbent assay.
Results: NK92 and primary NK cells were promptly infected by three viruses, as
demonstrated by virus presence (DNA) and transcription (RNA) analysis. Our data show
STING/STAT6 up-modulation in HHV-6A infected NK cells. NK cells infected with HHV-
6B and HHV-7 up-regulated CCL3, IFN-alpha, TNF-alpha, IL-8 and IFN-gamma and
slightly induced IL-4, and CCL4. HHV-6A infected NK cells up-regulated IL-4 and IL-13
and slightly induced IL-10, TNF-alpha, IFN-alpha, and IFN-gamma.
Conclusion: For the first time, we demonstrate that HHV-6A, HHV-6B, and HHV-7
infections have a differential impact on intracellular DNA sensors. HHV-6B and HHV-7
mainly lead to the active control of in vivo viral spreading by pro-inflammatory cytokine
secretion via TLR9. HHV-6A infected NK cells conversely induced STING/STAT6
pathway, as a mechanism of anti-viral activation, but they were characterized by a Th2
type response and a non-cytotoxic profile, suggesting a potential novel mechanism of
HHV-6A-mediated immunosuppression.
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INTRODUCTION
Three herpesviruses gaining medical interest are the human herpesvirus-6 (HHV-6) A and B and
human herpesvirus-7 (HHV-7). They are members of the Herpevirales order, Herpesviridae family,
Betaherpesvirinae subfamily, and Roseolavirus genus.
HHV-6, as HHV-6A and HHV-6B are commonly called when they are not separated into two
species, has a wide cell tropism inducing a lifelong latent infection in humans (Ablashi et al., 2014;
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Eliassen et al., 2017). HHV-6A/B replicate preferentially in CD4+
T lymphocytes and utilize distinct cell surface receptors: HHV-6A
uses CD46, a regulator of complement activation expressed on all
nucleated cells, while HHV-6B uses CD134 (also called OX40), a
member of the tumor necrosis factor (TNF) receptor superfamily.
HHV-6 infects also CD8+ T lymphocytes, NK cells, astrocytes,
microglial cells oligodendrocytes, liver cells, human fibroblasts,
epithelial cells, endothelial in vitro cells (De Bolle et al., 2005).
Human herpesvirus-7 has a narrow tropism for CD4+
T-cells, where it uses the glycoprotein CD4 for cell entry
(Lusso et al., 1994).
Human herpesvirus-6 and HHV-7 are immune-modulating
and modify the secretion of chemokines and cytokines, with
a significant effect on host immune response (Lusso, 2006;
Yoshikawa et al., 2009).
Currently, few studies are available on HHV-6 and HHV-7
infection of Natural killer (NK) cells, probably due to the absence
of reliable animal models.
Natural killer cells are able to kill tumor cells and virus-
infected cells independently of MHC restriction. Patients lacking
NK cells are subject to multiple infections by HHV, evidencing
their importance in viral immuno-surveillance in vivo (van Erp
et al., 2019). Several studies demonstrate NK-cell-dependent
protective effects during viral infections (Vidal et al., 2011), with
a direct killing of infected target cells and production of cytokines
(e.g., interferon (IFN)-γ) (Blanc et al., 2011).
HHV-6A/B can infect NK cells (Rizzo et al., 2017). We
have reported that NK cells are permissive to both HHV-
6A and HHV-6B viruses establishing a lytic replication. Both
viruses affect the expression of miRNAs implicated in NK
cell development, maturation and functions (miR-146, miR-
155, miR-181, miR-223). Moreover, HHV-6A/6B infections
modify the expression of transcription factors, with both species
increasing ATF3, JUN, and FOXA2, whereas HHV-6A inducing
POU2AF1 decrease, and HHV-6B FOXO1 increase, and ESR1
decrease. HHV-6B evades the elimination of infected cells by
suppressing surface expression of ligands for NK cell receptors
NKG2D and NKp30 (Schmiedel et al., 2016). Meanwhile,
the up-regulation of IL-15 production induced by HHV-6A/B
and HHV-7 infection results in NK cell antiviral activity
(Atedzoe et al., 1997).
Human herpesvirus-7 U21 protein reduces NK activation and
cytotoxicity interacting with the NK cell activating ligand ULBP1
that is rerouted to the lysosomal compartment, and down-
regulating the surface expression of the NK activating ligands
MICA and MICB (Schneider and Hudson, 2011).
The germline-encoded pattern recognition receptors (PRR)
and DNA sensors facilitate the NK cells recognition of pathogens
during the initial stages of infection, activating downstream
signaling cascades and the secretion of type I IFN and pro-
inflammatory cytokines.
Endosomal DNA-sensor Toll-like receptor (TLR)-9 has
been shown to recognize microbial DNA and induces the
host defense against infections (Kawai and Akira, 2010),
such as Human cytomegalovirus (HCMV), Herpes simplex
virus (HSV)-1 (Hochrein et al., 2004) and HSV-2 (Lund
et al., 2003). The hexamers containing unmethylated CpG
(cytosine-phosphate-guanine dideoxynucleotide) motifs are the
preferential ligands of TLR9 (Hemmi et al., 2000).
Upon HHV infection, viral DNA or aberrantly localized
cellular DNA are recognized by the DNA sensor cyclic GMPAMP
(cGAMP) synthase (cGAS) that forms the second messenger
2′3′-cGAMP (Diner et al., 2013). cGAMP interacts with the
endoplasmic reticulum (ER)-resident adaptor protein stimulator
of interferon genes (STING) that dimerizes and translocates
from the ER to the Golgi apparatus (Dobbs et al., 2015).
Here, Tank-binding kinase 1 (TBK1) is recruited for the
interferon regulatory factor 3 (IRF3) phosphorylation. IRF3
dimerizes (Tanaka and Chen, 2012) and translocates into the
nucleus, inducing the expression of type I IFN. STING can
also recruit Signal transducer and activator of transcription
(STAT)6 to the endoplasmic reticulum, where it dimerizes and
translocates to the nucleus, inducing target genes involved
in immune cell homing, such as chemokines (Chen et al.,
2012). Gamma-interferon-inducible protein 16 (IFI16) is a
cytosolic DNA sensor (Diner et al., 2013) of the Pyrin and
HIN domain (PYHIN) protein family. In the presence of
HHV infection, IFI16 translocates to the cytoplasm where it
induces STING-mediated signaling (Almine et al., 2017) or
synergizes with cGAS as a DNA co-sensor (Almine et al., 2017;
Dunphy et al., 2018).
The role of DNA sensors in NK cell anti-HHV-6 and HHV-
7 response is unclear and additional studies are needed to
understand the biological consequences on pathway signaling.
Here, we examine the role of DNA sensors in human NK cells
infected by HHV-6 and HHV-7.
MATERIALS AND METHODS
NK Cells
Natural killer 92 (ATCC CRL-2407) cell line was grown
in MEM-Alpha medium (Minimal Essential Medium, Gibco
BRL, Invitrogen Corporation, Carlsbad, CA, United States)
supplemented with 20% of FCS (fetal calf serum, Euroclone, Pero,
MI, Italy), 0.1 mM 2-Mercaptoethanol (Gibco BRL, Invitrogen
Corporation, Carlsbad, CA, United States), 100 U/mL penicillin,
100 µg/mL streptomycin and 150 U/mL of IL-2. Cell cultures
were maintained at 37◦C in humidified atmosphere of 5% CO2
in air. For stimulation of DNA sensors we used 2′,3′-cGAMP
(Sigma-Aldrich, St. Louis, MO, United States) 1 µM for 30 min in
digitonin permeabilization buffer (50 mM HEPES, 100 mM KCl,
3 mM MgCl2, 0.1 mM DTT, 85 mM sucrose, 0.2% BSA, 1 mM
ATP, 0.1 mM GTP, pH 7.0) (Srikanth et al., 2019).
Human primary NK cells were obtained from the peripheral
blood of healthy blood donors. This study was approved by the
“Ferrara Ethics Committee” and we collected written informed
consent from all subjects. All subjects gave written informed
consent in accordance with the Declaration of Helsinki.
Primary NK cells were separated from peripheral blood
samples using the negative magnetic cell separation (MACS)
system (Miltenyi Biotec, Gladbach, Germany) (Marci et al.,
2016). The analysis of purified cell fraction by flow cytometry
with CD3-PerCp-Cy5.5, CD56-FITC moAbs (e-Bioscience,
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Frankfurt, DE), demonstrated that the NK cell content was
>90% (data not shown). NK cells were treated with different
mRNA sensors or DNA sensors antagonists/inhibitors. We
used: ODN 2087 (Miltenyi Biotec), TLR7 and TLR8 antagonist
(0.5 µM); TLR3.CI (Calbiochem, Merck, Darmstadt, Germany),
TLR3/dsRNA Complex Inhibitor (30 nM); ODN 2088 (Miltenyi
Biotec), TLR7, TLR8, TLR9 antagonist (0.5 µM); H-151
(Invivogen; San Diego, CA, United States) STING antagonist
(0.5 µM) (Haag et al., 2018); A15117499 (Sigma-Aldrich,
Saint Louis, MS, United States) STAT6 inhibitor (100 nM)
(Chiba et al., 2009). To confirm the efficacy of mRNA
sensors antagonists/inhibitors, we used synthetic agonists. R-848
(Invivogen), a TLR-7/8 agonist (Gorden et al., 2005) (28), was
dissolved in dimethyl sulfoxide (Sigma-Aldrich, St. Louis, MO,
United States) at a concentration of 10 mM and stored at 4◦C.
It was used at the concentration of 3 µM (Gorski et al., 2006).
Poly I:C (Sigma-Aldrich), an agonist of TLR3, was reconstituted
at 2.5 mg/ml at 50◦C and re-annealed before storage at−20◦C. It
was used at the concentration of 25 µg/ml.
HHV-6A, HHV-6B and HHV-7 Infection
Cell-free virus inocula were obtained as previously described:
HHV-6 variant A (strain U1102) was grown in the J-Jhan cell
line (Rotola et al., 1998); HHV-6 variant B (strain Z29) and
HHV-7 (strain CZ) (Portolani et al., 1995) were grown in the
Sup T1 cell line.
RNA cell extraction was performed with the RNeasy kit
(Qiagen, Hilden, Germany). The absence of contaminant DNA in
the extracted RNA was assured by DNase treatment and control
β-actin PCR without retrotranscription reverse transcription
(Caselli et al., 2017; Rizzo et al., 2017). The analysis of virus
transcripts was preformed by RNA reverse transcription with
the RT2 First strand kit (Qiagen, Hilden, Germany) using
cDNA aliquots obtained from 200 ng RNA (Menegazzi et al.,
1999; Caselli et al., 2012). We used specific primers for HHV-
6 or HHV-7 U42 gene, respectively (Caselli et al., 2012).
The sequences are reported in Table 1. Each sample was
run in duplicate.
We also evaluated the transcription of latent (EBNA1, EBNA-
2, LMP1) and lytic (BAL2) genes of Epstein-Barr virus (EBV),
that latently infect NK92 cell line. We used specific primers, as
previously reported (Isobe et al., 2004). The lymphoblastoid cell
line LCL-B95.8 (kind gift of Professor R. Dolcetti) was used as
control of EBV gene expression, after viral cycle activation using
TPA (12-O-tetradecanoylphorbol-13-acetate) (Sigma-Aldrich),
used at 20 ng/ml.
Immunofluorescence Assay
Human herpesvirus-6 gp116 and HHV-7 KR4 late antigens’
expression was analyzed by immunofluorescence with anti-
gp116/64/54 FITC antibody (Ab) (Clone 6A5) (Santa Cruz,
United States) or KR4 (a kind gift of HHV-6 foundation),
as previously described (Caselli et al., 2012). STING/STAT
expression was evaluated with anti-STING PE Ab (Clone T3-680)
(BD Biosciences, Italy) and anti-STAT6 FITC (Clone D-1) (Santa
Cruz, United States).
TABLE 1 | U42 primers.
Gene Primers
HHV-6 U42 (Mirandola et al., 1998) Forward 3′ACGATGGACATGGCTTGTTG5′
Reverse 3′ACCTTACAACGGAGACGCC5′
HHV-7 U42 (Menegazzi et al., 1999) Forward 3′AAGCTGCAAGACGGAGTTGT5′
Reverse 3′AGTATTCCGGTGAAGCACGA5′
RNA and DNA Sensor mRNA Analysis
Toll-like receptor 3, TLR7, and TLR8 mRNA were analyzed
using the set of primers: TLR3 (F:5′-GAGGCGGGTGTTT
TTGAACTAGAA-3′, R:5′-AAGTCAATTGTCAAAAATAGG
CCT-3′) (Menager et al., 2009); TLR7 (F:5′-AGTGTCTAAA
GAACCTGG-3′, R:5′-CTTGGCCTTACAGAAATG-3′); and
TLR8 (F:5′-CAGAATAGCAGGCGTAACACATCA-3′,R:5′ATG
TCACAGGTG CATTCAAAGG -3′) (Hart et al., 2005).
Toll-like receptor 9 and STING mRNA were analyzed
using the set of primers: TLR9 5′-CCGTGACAATTACCTGGC
CTTC-3′ (forward) and 5′-CAGGGCCTTCAGCTGGTTTC-
3′ (reverse) (Bao et al., 2016); STING: Fw: 5′-GCTGCTG
TCCATCTATTTCTACT-3′ (forward) and 5′-GCCGCAGATAT
CCGATGTAATA-3′ (reverse) (Gram et al., 2017). Actin was used
as house-keeping gene and was analyzed with the set of primers:
5′-GATGGAGTTGAAGGTAGTTT-3′ (forward) and 5′- TGC-
TATCCAGGCTGTGCTAT-3′ (reverse) (Rizzo et al., 2017).
Cytokine mRNA Analysis
Uninfected or HHV infected NK92 cells were stimulated with
CpG 25 µg/ml CpG (ODN 2006, TIB MOLBIOL) ml 3d.p.i., and
the cells were collected 24 h after stimulation. Cytokine mRNAs
were analyzed with Real-Time PCR assays for human genes: IFN-
alpha: Hs03044218-g1; IL-6: Hs00174131; IL-8: Bt03211906; IL-
22: Hs01574154; TNF-alpha: Hs02621508 (Applied Byosystems;
ThermoFisher Scientific; United States).
Cytokine/Chemokine Enzyme
Immunosorbent Assay
Levels of CCL3, CCL4, CCL5, IL-4, IL-8, IL-10, IL-13, IFN-
alpha, TNF-alpha, IL-8, IFN-gamma were assessed in duplicates
in cell culture supernatants using commercial human specific
enzyme-linked immunosorbent assays (ELISAs) (myBiosource,
United States) following manufacturer’s protocols.
Western Blot Analysis
Whole cell lysates were prepared by using the RIPA buffer
containing proteinase inhibitor cocktail (Sigma-Aldrich, St.
Louis, MO, United States). Proteins were quantified by means
of the Bradford assay (Bio-Rad; Segrate, MI, Italy) using
bovine albumin (Sigma-Aldrich) as standard. Twenty µg of
total proteins were loaded in each well and evaluated in
denaturating conditions in 10% TGX-Pre-cast gel (Bio-Rad),
with subsequent electroblotting transfer onto a PVDF membrane
(Millipore, MA, United States). The membrane was incubated
with a specific antibody for the protein to be analyzed, then
with a horseradish peroxidase (HRP)-conjugated anti-mouse
antibody (1:5000; Amersham Biosciences, NJ, United States)
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and developed with the ECL kit (Amersham Biosciences, NJ,
United States). The images were acquired by Geliance 600
(Perkin Elmer, MA, United States). The specific antibodies
used were: anti-Myd88 (Clone 4D6), anti-STING (Clone
TMEM173), anti-cGAS (CL3605), anti-IFI16 (Clone 2E3), anti-
TBK1 (Clone 108A429), anti-IRF3 (Clone SD2062), anti-STAT6
(Clone 177C322.1) (Novus Biologics; Italy), anti-IRF3 Ser396
(Clone 4D4G), and anti STAT6 Tyr641 (Clone D859Y) (Cell
signaling Technology; United States). The complete Western
Blots are reported in Supplementary Figures S2, S3.
Intracellular TLR9 Expression by Flow
Cytometry
Intracellular expression of TLR9 was quantified fixing NK92
cells with 2% formaldehyde and permeabilizing them for
intracellular staining with anti-TLR9-PE (Clone anti-GJ15A7)
(BD Biosciences). Cells were analyzed by flow cytometry (FACS
Canto II, BD) and FlowJo software (Tree Star Inc). Viable cells
were assessed by propidium iodide. Approximately 105 cells were
collected for each individual sample.
Statistical Analysis
Since the biological variables presented a normal distribution
(Kruskal–Wallis test, p > 0.05), they were evaluated by Student
t test by Graph pad software. A p-value < 0.05 was defined
statistically significant.
RESULTS
HHV-6A, HHV-6B and HHV-7 Infect NK
Cells
As previously reported, HHV-6A and HHV-6B viruses can infect
NK cells (Rizzo et al., 2019). Here we showed that NK92 cells are
permissive to HHV-6A, HHV-6B, and HHV-7, with a high viral
amount 3 days post infection (d.p.i.) using 100 multiplicity of
infection (m.o.i.) (Figure 1A). In Figures 1B,C, the expression of
DNA and mRNA of U42, an immediate early HHV-6 viral gene,
increased during the 6 d.p.i. that were evaluated. Similarly, using
HHV-7 U42 specific primers, the expression of both DNA and
mRNA increased significantly. We selected the time point 3d.p.i.
to perform the subsequent experiments, since it coincides with a
high viral amount for both HHV-6 and HHV-7. When we looked
at viral late antigens at 3 d.p.i., in particular gp116 for HHV-6 and
KR4 for HHV-7, we observed their expression (Figure 1D).
Since NK92 cells arbor a latent EBV infection, we wanted
to be sure that it did not affect the results observed. The
analysis of latent (EBNA1, EBNA-2, LMP1) and lytic (BZLF1)
EBV genes showed no mRNA transcription (Supplementary
Figure S1), supporting the absence of any confounding effect of
EBV latent infection.
HHV-6A, HHV-6B and HHV-7 Infection
Affects TLR9 Expression
To further dissect and understand the modification induced
by HHV-6 and HHV-7 infection of NK cells, we performed
the analysis on NK92 cell line to have reproducible data not
affected by individual differences in NK cell subpopulations.
First, we considered the DNA sensor protein TLR9 (Roda
et al., 2005). We infected NK cells with HHV-6A, HHV-6B
or HHV-7, and evaluated TLR9 mRNA expression at 3 d.p.i.
comparing TLR9 mRNA levels in HHV infected cells with those
in uninfected NK92 cells.
At mRNA level, we observed that HHV-6A inhibited the
expression of TLR9 mRNA and protein (p < 0.001; Student
t test) (Figures 2A,B). HHV-6B and HHV-7 did not affect
the TLR9 mRNA expression but we observed a decrease in
protein expression after HHV-6B infection (p = 0.023; Student
t test) (Figures 2A,B). When we looked at the TLR9 pathway,
we considered the key component Myd88. No modifications
were observed in the expression levels of this protein in the
NK92 cells infected with any of the three viruses (Figure 2C).
These data suggest that the decrease in TLR9 protein expression
observed in HHV-6A infected NK92 cells is restricted to the
TLR9 gene. Since the expression of TLR9 is fundamental for
the pathway activation and transcription of IFN-alpha and pro-
inflammatory cytokines (e.g., IFN-alpha, TNF-alpha, IL-6, IL-8,
and IL-22), we evaluated the cytokines’ mRNA expression by
NK92 cells 3 d.pi. HHVs infection and 24 h of stimulation
with unmethylated CpG DNA motif, the ligand for TLR9
activation. We observed that NK92 cells express TLR3, TLR7, and
TLR8 mRNA sensing molecules (Supplementary Figure S2B).
To be sure that their activation does not affect the results
obtained, we inhibited them with specific antagonists (ODN2087:
TLR7, TLR8 antagonist; TLR3.CI: TLR3 antagonist). The efficacy
of RNA sensors’ antagonists was demonstrated by activating
the cells with the corresponding agonists (Supplementary
Figure S2C). We used synthetic agonists, R-848 (Invivogen),
a TLR-7/8 agonist and Poly I:C (Sigma-Aldrich), an agonist
of TLR3. We tested the relative mRNA expression of type
I interferon (IFN-alpha) (Tabeta et al., 2004; Uematsu and
Akira, 2007), as marker of TLR3, TLR7, TLR-8 activation
in NK92 cells treated with TLR7/8, TLR3 agonists with
or without antagonists treatment. We observed an increase
in IFN-alpha levels in TLR7/8, TLR3 agonists treated cells,
while the antagonist treatment inhibits the induced expression
of IFN-alpha (Supplementary Figure S2C). We showed an
increase in IFNA-alpha, TNF-alpha, and IL-8 expression in
HHV-6B and HHV-7 infected NK92 cells (Figure 2D), with
the highest levels reached by IL-8 with HHV-7 infection
(p < 0.001; Student t test). On the contrary, TNF-alpha and IL-
8 expression was slightly modified in HHV-6A infected NK92
cells (Figure 2D). IL-6 and IL-22 were not induced by the viruses
(data not shown).
HHV-6A, HHV-6B and HHV-7 Infection
Affects STING Expression and Activation
Pathway
We then considered the DNA sensor protein STING. The
stimulation of the cytoplasmic DNA sensing pathways was
performed with 2′,3′-cGAMP. At mRNA level, we observed
increased levels of STING expression during HHV-6A infection
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FIGURE 1 | NK92 infection by HHV-6A, HHV-6B and HHV-7. (A) NK92 cells were infected with HHV-6A, HHV-6B or HHV-7 at different multiplicity of infection (1.0,
10.0, 50.0, 100.0, 200.0 m.o.i.). The virus presence (U42 DNA) was evaluated 3 days post infection (d.p.i.). Virus (B) presence (DNA) and (C) transcription (RNA)
were evaluated, respectively, by qPCR and RT-qPCR performed on U42 virus gene, at 1, 2, 3, and 6 d.p.i., as already detailed. The infection was performed with
100 m.o.i. (D) HHV-6A and HHV-6B infected NK92 cells were characterized by immunofluorescence for gp116 (late viral protein) expression 3d.p.i. HHV-7 infected
NK92 cells were characterized by immunofluorescence for KR4 (late viral protein) expression 3d.p.i. Uninfected NK92 cells (CTR) were used as control. Images were
taken in bright field (left panels) or fluorescence (right panels) (Nikon Eclipse TE2000S) equipped with a digital camera. Original magnification 20×.
and cGAMP treatment (p < 0.001; Student t test), while
HHV-6B and HHV-7 did not affect STING mRNA expression
(Figure 3A). When we considered protein expression, we did
not observe any induction of STING expression in all the four
conditions (Figure 3B).
When we looked at STING pathway, we considered the key
components cGAS and IFI16 as up-stream regulators of STING
activation, TBK1 and IRF3 for the NFkB activation pathway and
STAT6 for the STAT6-dependent pathway.
cGAs protein expression was not modified by HHV-6A and
HHV-6B and only slightly decreased by HHV-7 (p = 0.038;
Student t test). IFI16 protein expression was not modified
by HHV-7, while it was down-modulated by HHV-6A and
HHV-6B infection (p = 0.033; Student t test) (Figure 3C).
NK92 cell infection induced TBK1 expression (Figure 3C),
mainly after HHV-6A infection (p = 0.011; Student t test).
Notably, the Western Blot of TBK1 presented the control
lane with a lighter background in comparison with the HHV
lanes. We hypothesize that TBK1 moAb might cross-reacts
with some HHV proteins and creates a darker background.
IRF3 protein expression and Ser396 phosphorylation were not
up-regulated by the three viruses. On the contrary, STAT6
Tyr641 phosphorylation was induced by HHV-6A (Figure 3C)
(p = 0.022; Student t test). HHV-6B and HHV-7 did not
induce STAT6 expression (Figure 3C). The peculiar activation of
STING/STAT6 pathway in HHV-6A infected NK92 cells seems
to be confirmed by the different cellular localization of STING
and STAT6 (Figure 3D). We observed that already after 3d.p.i.
STING and STAT6 co-localized in the peri-nuclear/cytoplasmic
region of the HHV-6A infected NK92 cells, that express the late
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FIGURE 2 | TLR9 analysis. TLR9 (A) mRNA relative expression and (B) endosomal protein expression in uninfected, HHV-6A, HHV-6B or HHV-7 infected NK92 cells
3 d.p.i. NK92 cells were intracytoplasmic stained for anti-TLR9-PE (Clone anti-GJ15A7). Representative histograms are reported. The histograms showed the MFI
(mean fluorescence intensity) values of three independent experiments. ∗p values Student t test. (C) Western Blot analysis for house-keeping actin (upper blot) and
Myd88 (lower blot, a red arrow indicates the localization of the bands of interest) expression in uninfected (CTR), HHV-6A, HHV-6B or HHV-7 infected NK92 cells 3
d.p.i. The molecular weights were determined by protein ladder (14.4-97.4kDa) (BioRad). Actin was evidenced at 44kDa, Myd88 at 33kDa. The images were
acquired by Geliance 600 (Perkin Elmer, MA, United States). The complete Western Blots are reported in Supplementary Figure S2. (D) Relative mRNA expression
of IFN-alpha, TNF-alpha, IL-8 in HHV-6A, HHV-6B or HHV-7 infected NK92 cells in comparison with uninfected NK92 cells. The cytokines’ mRNA expression was
evaluated in NK92 cells 3 d.pi. HHVs infection, 24 h of stimulation with unmethylated CpG DNA motif and with RNA sensor antagonists (ODN 2087 (Miltenyi Biotec),
TLR7 and TLR8 antagonist (0.5 µM); TLR3.CI (Calbiochem, Merck, Darmstadt, Germany), TLR3/dsRNA Complex Inhibitor (30 nM).
gp116 viral antigen (Figure 3D). On the contrary, the localization
of STING and STAT6 in control NK92 cells was prevalently
cytosolic (Figure 3D, lower panel).
HHV-6A, HHV-6B and HHV-7 Infection
Affects NK Cell Cytokines/Chemokines
Secretion
The activation of DNA sensor proteins is responsible for the
expression of cytokines and chemokines (Diner and Cristea,
2015). We evaluated the effect of the activation of the different
pathways (TLR9, STING, STAT6) due to viral infections on
the cytokine and chemokine expression by primary NK cells.
We purified NK cells from peripheral blood samples of five
control subjects and infected them with 100 m.o.i. for 3 days
(Supplementary Figure S4), in the presence of mRNA sensor
molecules antagonists/inhibitors (ODN2087: TLR7, TLR8
antagonist; TLR3.CI: TLR3 inhibitor) differently combined
with DNA sensor molecules antagonists/inhibitors (ODN2088:
TLR9 antagonist; H151: STING antagonist; AS1517499:
STAT6 inhibitor).
We observed a different cytokine/chemokine expression
during viral infections in the presence of different inhibitors. In
the presence of mRNA sensor molecules antagonists/inhibitors,
HHV-6A infected NK cells up-regulated IL-4 and IL-13 and
slightly induced IL-10, TNF-alpha, IFN-alpha, and IFN-gamma
(Figure 4A). NK cells infected with HHV-6B and HHV-7 up-
regulated CCL3, IFN-alpha, TNF-alpha, IL-8, and IFN-gamma
and slightly induced IL-4 and CCL4.
When we added the TL9 antagonist ODN2088, we observed
no more induction in TNF-alpha, IFN-alpha, IL-8, and IFN-
gamma in HHV-6A infected NK cells (Figure 4B). The TLR9
antagonists drastically reduced the secretion of CCL3, IFN-
alpha, TNF-alpha, IL-8, and IFN-gamma in HHV-6B and HHV-
7 infected NK cells (Figure 4B). The addition of STING
antagonist H151 reduced cytokine/chemokine secretion by
HHV-6A infected NK cells, maintaining only IFN-alpha levels
unaltered (Figure 4C). IN HHV-6B and HHV-7 infected NK
cells there was only a slight reduction in IFN-alpha, TNF-alpha,
and IL-8 secretion (Figure 4C). The addition of STAT6 inhibitor
AS1517499 in HHV-6A infected NK cell cultures resulted in a
similar reduction of cytokine/chemokine secretion observed with
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FIGURE 3 | STING pathway analysis. (A) STING mRNA relative expression in uninfected (CTR), HHV-6A, HHV-6B or HHV-7 infected NK92 cells 3d.p.i. ∗p values
Student t test; (B) Western Blot analysis for house-keeping actin (upper blot) and STING (lower blot) expression in uninfected (CTR), HHV-6A, HHV-6B or HHV-7
infected NK92 cells 3d.p.i. For stimulation of the cytoplasmic DNA sensing pathways, we used 2′,3′-cGAMP. The molecular weights were determined by protein
ladder (14.4-97.4kDa) (BioRad). Actin was evidenced at 44kDa, STING 35kDa. The images were acquired by Geliance 600 (Perkin Elmer, MA, United States). The
complete Western Blots are reported in Supplementary Figure S3. ∗p value Student t test. The histogram represents the STING band intensity in relation with the
corresponding actin band. (C) Western Blot analysis for house-keeping actin (upper blot) and cGas, IFI16, TBK1, IRF3, pIRF3Ser396, STAT6, pSTAT6Tyr641 (lower
blots) expression in uninfected (CTR), HHV-6A, HHV-6B or HHV-7 infected NK92 cells 3 d.p.i. The molecular weights were determined by protein ladder (25-250kDa;
14.4-97.4 kDa). Actin was evidenced at 44kDa, cGas at 68kDa, IFI16 at 100kDa, TBK1 at 80kDa, IRF3 at 55kDa, STAT6 at 120kDa. The histogram represents the
STING band intensity in relation with the corresponding actin band. ∗p value Student t test. The images were acquired by Geliance 600 (Perkin Elmer, MA,
United States). The complete Western Blots are reported in Supplementary Figure S3. (D) HHV-6A infected NK92 cells were characterized by
immunofluorescence for STING [anti-STING PE Ab (Clone T3-680)], STAT6 [anti-STAT6 FITC (Clone D-1)] and gp116 (Clone 6A5) expression. (Nikon Eclipse
TE2000S) equipped with a digital camera. Original magnification 100×. Uninfected NK92 cells were used as control.
the STING antagonist H151 (Figure 4D). AS1517499 slightly
reduced the secretion of CCL3, CCL4, TNF-alpha, and IL-8 in
HHV-6B and HHV-7 infected NK cells (Figure 4D).
DISCUSSION
Here, we evaluated the effect of HHV-6A, HHV-6B, and HHV-7
NK cell infection on DNA sensor molecules. We used, for the first
set of experiments, NK92 cell line to avoid individual differences
in NK cell subpopulations. The confirmatory experiments
were performed on primary NK cells obtained from control
subjects. We found that the three viruses affect the DNA
sensors in NK cells differently.
TLR 9 mRNA and protein levels were inhibited by HHV-6A
infection but no effect was observed in the protein expression
of Myd88, a downstream mediator of the TLR9 pathway. These
data suggest a particular impairment in the TLR9 pathway during
HHV-6A infection, that is slightly evident only during HHV-6B
but not HHV-7 infection. As a proof of concept, the analysis
of the TLR9 down-stream genes’ activation (Huang and Yang,
2010), in the presence of mRNA sensor molecules (TLR3, TLR7,
TLR8) antagonists/inhibitors, showed that HHV-6B and HHV-7
infections induced an increase in TNF-alpha and IL-8 expression,
with the highest levels reached by IL-8 during HHV-7 infection.
On the contrary, HHV-6A infection slightly modified TNF-alpha
and IL-8 expression. TLR9 signaling is essential for the early
cytotoxicity of NK cells during infections (Liese et al., 2007). The
reduction of TLR9 expression in HHV-6A infected NK cells leads
to an impaired cytokine expression that might prevent NK cells
activation toward target cells and slow down the inflammatory
response needed to fight the infection. On the contrary HHV-
6B and HHV-7 induced TNF-alpha and IL-8 secretion by NK
cells, as previously reported for astrocyte cultures (Chi et al.,
2012), where HHV-6 infection promoted transforming growth
factor β (TGF-β), IL-6, IL-8, and TNF-alpha production. During
HHV-6B and HHV-7 infection, we observed a high expression
of IL-8, as previously reported in HHV-6 infected Hep G2 liver
cells (Inagi et al., 1996), where a significant induction of IL-8
gene expression was observed. These data suggest that HHV-
6B and HHV-7 may induce a cytokine-mediated inflammatory
response infecting NK cells. On the contrary, HHV-6A reduced
pro-inflammatory cytokine release, which could result in NK cell
dysfunction in vivo.
STING mRNA expression was increased during HHV-6A
infection, but not during HHV-6B and HHV-7 infection.
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FIGURE 4 | NK cell cytokine/chemokine protein amount. The concentrations of cytokines in the culture supernatants of HHV-6A, HHV-6B or HHV-7 infected primary
NK cells 3d.p.i. were quantified by immunoassays (CCL3, CCL4, CCL5, IL-4, IL-8, IL-10, IL-13, IFN-alpha, TNF-alpha, IL-8, IFN-gamma) (myBiosource,
United States. The data are presented as relative to the expression of uninfected primary NK cells. Five donors have been analyzed and the data are the mean of the
results obtained. The cell were treated with RNA/DNA sensor antagonists/inhibitors: (A) ODN 2087 TLR7 and TLR8 antagonist (0.5 µM) + TLR3.CI TLR3/dsRNA
Complex Inhibitor (30 nM); (B) TLR3.CI TLR3/dsRNA Complex Inhibitor (30 nM) + ODN 2088 (Miltenyi Biotec), TLR7, TLR8, TLR9 antagonist (0.5 µM); (C) ODN
2087 TLR7 and TLR8 antagonist (0.5 µM) + TLR3.CI TLR3/dsRNA Complex Inhibitor (30 nM) + H151 STING antagonist (0.5 µM); (D) ODN 2087 TLR7 and TLR8
antagonist (0.5 µM) + TLR3.CI TLR3/dsRNA Complex Inhibitor (30 nM) + AS1517499 STAT6 inhibitor (100 nM). The green squares are representative of slight
differences that do not reach the a significant statistical value.
Strangely, STING protein levels were not modified by all the three
viruses, suggesting that the over-production of STING mRNA
during HHV-6A infection is degraded, probably to convey the
transduction machinery to the viral mRNAs. Similarly, 2′,3′-
cGAMP affected only mRNA but not protein expression. Since
STING is already efficiently expressed, we can hypothesize
that 2′,3′-cGAMP affects the transcription of mRNA that
is then degraded.
When we looked at STING pathway, we observed that TBK1
protein expression is induced by all three viruses, but without an
enhanced IRF3 Ser396 phosphorylation. On the contrary, STAT6
Tyr641 phosphorylation was induced only by HHV-6A with a
perinuclear co-localization of STING and STAT6 at 3 d.p.i. in
HHV-6A infected cells, as suggested by the co-localization with
the gp116 late antigen. It has been already shown that viruses or
cytoplasmic nucleic acids trigger STING to recruit STAT6 to the
ER, where it is phosphorylated on Ser407 by TBK1 and on Tyr641
by IL-4/IL-13 pathway (Chen et al., 2003). Dimerized STAT6
then translocates to the nucleus where it induces target genes
responsible for immune cell homing. We have evaluated only
STAT6 Tyr641 phosphorylation since there are no commercial
antibodies available toward Ser407. However, since TBK1 is
induced in HHV-6A infected NK92 cells, we can hypothesize
that both Ser407 and Tyr641 might be phosphorylated in HHV-6A
infected NK92 cells and lead to down-stream genes’ transcription.
As a proof of concept, Atf3 transcription factor, that we have
previously found up-modulated by HHV-6A infection of NK
cells, is induced by IL-4 through STAT6 (Chen et al., 2003),
supporting the activation of STING/STAT6 pathway.
cGAS protein levels were down-modulated by HHV-7
infection, while HHV-6A and HHV-6B remained at a basal
level. IFI16 protein expression was down-modulated by HHV-
6A and HHV-6B infection, while it remained at a basal
level during HHV-7 infection. These results might confirm
previous papers on HSV-1 that induced the degradation of IFI16
by a proteasome and apparently ICP0-dependent mechanism
(Orzalli et al., 2012). Similarly, HHV-6A and HHV-6B seem
to maintain the cGAS up-stream activation of STING pathway.
On the contrary, HHV-7 data support the role of IFI16 as
the primary HHV DNA sensor and restriction factor (Gariano
et al., 2012), where cGAS has an indirect role in the presence
of nuclear HHV DNA by interacting and stabilizing IFI16
(Orzalli et al., 2015).
The analysis of cytokines/chemokines secretion in HHV
infected primary NK cells, showed a different behavior in
the presence of the different viruses. The NK cell response
seem to be similar in the presence of both HHV-6B and
HHV-7 viral infection. NK cells express mainly CCL3, IFN-
alpha, TNF-alpha, IL-8, and IFN-gamma. The use of DNA
sensors antagonists assigns to TLR9 the main effect on
cytokines/chemokines expression. On the contrary, HHV-6A
infection of NK cells induced IL-4, IL-10, and IL-13. The
addition of antagonists/inhibitors against STING and STAT6
reduced drastically the secretion of these cytokines by NK
cells, supporting the activation of STING/STAT6 pathway as
predominantly implicated in the response of NK cells to HHV-6A
infection. These results suggest a chemoattractant role for
cytokine/chemokine secreted by HHV-6B and HHV-7 infected
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NK cells, while HHV-6A infected NK cells showed a viral-driven
Th2 response (Kaiko et al., 2010).
Collectively, these results show an implication of TLR9 DNA
sensor in the cytokine/chemokine expression by NK cells infected
with HHV-6B and HHV-7. These might lead to the active
control of in vivo viral spreading. HHV-6A infected NK cells
conversely induced STING/STAT6 pathway, as a mechanism
of anti-viral activation, but were characterized by a Th2 type
response, providing a potential new mechanism used by HHV-
6A to induce immunosuppression and immune evasion (Horan
et al., 2013; Christensen and Paludan, 2017). To confirm these
results, further studies are needed, to dissect the viral mechanism
that leads to differential response of NK cells in the presence of
different HHV infections.
In conclusion, we have shown that HHV-6A, HHV-6B, and
HHV-7 infection of NK cells interact differently with cellular
DNA sensors. Strikingly, HHV-6B behaves similarly to HHV-7
compared to HHV-6A, confirming the difference of HHV-6A and
-6B in their molecular, epidemiological and biological properties
(Ablashi et al., 2014).
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FIGURE S1 | EBV mRNA expression of latent (EBNA1, EBNA-2, LMP1) and lytic
(BALF2) EBV genes in NK92 cell line. The lymphoblastoid cell line LCL-B95.8 (kind
gift of Professor R. Dolcetti) was used as control of EBV gene expression, after
viral cycle activation using TPA (12-O-tetradecanoylphorbol-13-acetate)
(Sigma-Aldrich), used at 20 ng/ml.
FIGURE S2 | (A) Complete Western Blots for Figure 2C. (B) RT-PCR for TLR3,
TLR7, and TLR8 expression in NK92 cell line. (C) Relative mRNA expression of
IFN-alpha in the culture supernatants of NK92 cells untreated or treated with
synthetic agonists (R-848, TLR7/8 agonist; Poly I:C, TLR3 agonist) with or without
ODN 2087 TLR7 and TLR8 antagonist (0.5 µM) + TLR3.CI TLR3/dsRNA
Complex Inhibitor (30 nM).
FIGURE S3 | Complete Western Blots for Figures 3B,C.
FIGURE S4 | Virus (A) presence (DNA) and (B) transcription (RNA) were
evaluated, respectively, by qPCR and RT-qPCR performed on U42 virus gene, at
1, 2, 3, and 6 d.p.i., as already detailed. The infection was performed with 100
m.o.i. in primary NK cells.
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